Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses

Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray

(2013) A.F. Almeida-Santos et al.   BEHAVIOURAL BRAIN RESEARCH

Modeling panic disorder in rodents

(2013) Fabrício A. Moreira et al.   CELL AND TISSUE RESEARCH

Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report

(2013) Mateus M. Bergamaschi et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze

(2013) Pedro H. Gobira et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats

(2013) A.F. Almeida-Santos et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications

(2013) Roger G. Pertwee   PROCEEDINGS OF THE NUTRITION SOCIETY

The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats

(2013) Jozsef Haller et al.   PSYCHOPHARMACOLOGY

Multiple Functions of Endocannabinoid Signaling in the Brain

(2012) István Katona et al.   Annual Review of Neuroscience

The many paths to fear

(2012) Cornelius T. Gross et al.   NATURE REVIEWS NEUROSCIENCE

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

(2012) R. G. Pertwee   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects

(2011) Gai Ling Li et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone

(2011) WM Olango et al.   BRITISH JOURNAL OF PHARMACOLOGY

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives

(2011) Eva M Marco et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neuroanatomical substrates involved in cannabinoid modulation of defensive responses

(2011) FA Moreira et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats

(2011) Plínio C Casarotto et al.   NEUROPSYCHOPHARMACOLOGY

Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test

(2009) Lucas LM Tonetto et al.   Behavioral and Brain Functions

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

(2009) Fabrício A. Moreira et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Blockade of NMDA receptors and nitric oxide synthesis in the dorsolateral periaqueductal gray attenuates behavioral and cellular responses of rats exposed to a live predator

(2009) Daniele Cristina Aguiar et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

(2009) J. Haller et al.   PSYCHOPHARMACOLOGY

Panic Disorder: Is the PAG Involved?

(2009) Cristina Marta Del-Ben et al.   NEURAL PLASTICITY

Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates

(2008) Zuzana Justinova et al.   BIOLOGICAL PSYCHIATRY

Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test

(2008) Sabrina F. Lisboa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

(2007) Fabricio A. Moreira et al.   NEUROPHARMACOLOGY